| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/27/2004 | EP0994901B1 Method for extracting, identifying, using active principles of marine mollusque shells |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | EP0832270B1 Cationic lipid:dna complexes for gene targeting |
| 10/27/2004 | EP0831877B1 Metabolic effects of certain glutathione analogs |
| 10/27/2004 | EP0831791B1 Delivery of drugs to the lower gi tract |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | EP0807125B1 Monoclonal antibodies anti-cd6 for the treatment and diagnosis of psoriasis |
| 10/27/2004 | EP0763107B1 Pantropic neurotrophic factors |
| 10/27/2004 | EP0763052B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 10/27/2004 | EP0759992B1 Human papilloma virus inhibition by a hairpin ribozyme |
| 10/27/2004 | EP0721015B1 Monoclonal antibody that induces apoptosis |
| 10/27/2004 | EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/27/2004 | CN1541335A EPF receptor assays, compounds and therapeutic compsns. |
| 10/27/2004 | CN1541275A Glycoprotein and process for producing same |
| 10/27/2004 | CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules |
| 10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541265A Identification of DNA variant associated with adult type hypolactasia |
| 10/27/2004 | CN1541263A Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms |
| 10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
| 10/27/2004 | CN1541126A Microprojection array having beneficial agent contg coating |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541106A Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 10/27/2004 | CN1541105A Combination therapies using vitamin B12 and interferon for treatment of viral, provliferative and inflammatory diseases |
| 10/27/2004 | CN1541104A Method for inducing onset of reproductive cycle of female breeding animals |
| 10/27/2004 | CN1541103A Methods for inducing sustained immune response |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541100A Calcium phosphate delivery vehicles for osteoinductive proteins |
| 10/27/2004 | CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation |
| 10/27/2004 | CN1541094A Treatment of lipodystrophy |
| 10/27/2004 | CN1541090A Prepn. of sustained release pharmaceutical compsn. |
| 10/27/2004 | CN1539986A Method for extracting composite polysaccharide AVDS possessing anticarcinogenesis from 'mao renshen' and medical usage |
| 10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
| 10/27/2004 | CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same |
| 10/27/2004 | CN1539505A Stable isotonic lyophilized protein formulation |
| 10/27/2004 | CN1539501A Tablet for keeping in mouth prepared from recombined human interferon alpha 2b and producing method |
| 10/27/2004 | CN1539500A Nose drops of recombined human interferon alpha 2b and preparing method |
| 10/27/2004 | CN1539499A Combination of stable interferon for lacal use |
| 10/27/2004 | CN1539385A Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering |
| 10/27/2004 | CN1173037C Single-chain bifunctional glycoprotein hormones |
| 10/27/2004 | CN1173034C TSA 305 gene |
| 10/27/2004 | CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 10/27/2004 | CN1172953C Gene sequence and amino-acid sequence of varient omega-conch toxin polypeptide and their preparing method and medicinal use |
| 10/27/2004 | CN1172952C Mannosan peptide and its prepn and use |
| 10/27/2004 | CN1172718C Dendritic cell stimulatory factor |
| 10/27/2004 | CN1172685C Aqueous solution for parenteral absorption |
| 10/27/2004 | CN1172672C Alpha-ketoamide multicatalytic protease inhibitors |
| 10/27/2004 | CN1172658C Protein formulations |
| 10/26/2004 | US6809194 For regulating cell growth/tumors; serine/threonine kinases (atk3) |
| 10/26/2004 | US6809193 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809185 Created by heterodimerization of immunoglobulin domains; have two or more antigen binding parts; for diagnosis/treatment of human diseases |
| 10/26/2004 | US6809182 Utlizing the varicella-zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery |
| 10/26/2004 | US6809181 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809176 Compounds for use in treatment of cancer |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809118 Histone deacetylase inhibitors; antiproliferative agents; antiinflammatory agents |
| 10/26/2004 | US6809112 Administering a sexually therapeutically effective amount of a compound having the formula like (5r)-5-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinoline-2(1h)-thione |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809079 Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6809075 To enhance the elasticity and/or appearance; low molecular weights; used in combination with retinoids, preferably tretinoin |
| 10/26/2004 | US6808930 Labelling reagent; can be used in diagnosis and therapy of cancer/tumors; detection of penetration of nucleus susceptible to alpha-lactalbumin (mal) |
| 10/26/2004 | US6808927 Use of tafia as an anticoagulant and inhibitors of tafis as procoagulants |
| 10/26/2004 | US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis |
| 10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| 10/26/2004 | US6808900 Test kits; genetic engineering |
| 10/26/2004 | US6808899 G protein-coupled receptor protein for use in treatment of nervous system disorders |
| 10/26/2004 | US6808898 Low oxygen affinity mutant hemoglobins |
| 10/26/2004 | US6808895 DNA encoding oxidoreductase and polypeptide encoded thereby |
| 10/26/2004 | US6808893 Glutamate transporter associated proteins and methods of use thereof |
| 10/26/2004 | US6808891 Modulators of the function of FAS/APO1 receptors |
| 10/26/2004 | US6808890 Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein |
| 10/26/2004 | US6808880 Method for detecting polynucleotides encoding telomerase |
| 10/26/2004 | US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 10/26/2004 | US6808876 Cellular regulators of infectious agents and methods of use |
| 10/26/2004 | US6808713 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 10/26/2004 | US6808712 Imunogenic a beta fragment linked to immunoglobulin carrier to form conjugate; adjuvant comprising antibodies to a beta fragment enhances immune response; alzheimer*s disease treatment |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808708 Compositions and methods relating to reduction of symptoms of autism |
| 10/26/2004 | US6808707 Wound healing compositions and methods using tropoelastin and lysyl oxidase |
| 10/26/2004 | US6808706 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 10/26/2004 | US6808705 For suppressing the proliferation of cancer cells |
| 10/26/2004 | CA2328060C Gene any-rf, dormancy-control substance and method for preparing the same as well as cell-control agent for biological cells |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2282407C Methods and compositions for optimization of oxygen transport by cell-free systems |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/26/2004 | CA2217122C Medical composition for curing thrombocytopenia |
| 10/26/2004 | CA2177616C Preparation and use of immunoconjugates |
| 10/26/2004 | CA2137237C Purified forms of dnase |
| 10/26/2004 | CA2080462C Therapeutic uses of actin-binding compounds |
| 10/26/2004 | CA1341461C T helper cell growth factor |
| 10/21/2004 | WO2004090151A2 Method for extracting collagen comprising microbial fermentation |
| 10/21/2004 | WO2004090135A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 10/21/2004 | WO2004090121A2 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 10/21/2004 | WO2004090120A2 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 10/21/2004 | WO2004090112A2 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 10/21/2004 | WO2004090109A2 Ccn3 compositions and methods |
| 10/21/2004 | WO2004090103A2 Identification of novel nogo-receptors and methods related thereto |